How much funding has Marksans Pharma raised?

Marksans Pharma has raised $43.5M in total funding, most recently a Venture Round.

Who are Marksans Pharma's investors?

Marksans Pharma's investors include OrbiMed.

When was Marksans Pharma founded?

Marksans Pharma was founded in 1992.

Where is Marksans Pharma headquartered?

Marksans Pharma is headquartered in Mumbai, India.

What industry is Marksans Pharma in?

Marksans Pharma operates in Biotech.

How many employees does Marksans Pharma have?

Marksans Pharma has 1001-5000 employees.

Marksans Pharma

IPO

Pharmaceutical Formulation Manufacturers in Mumbai, India

Public · Mumbai, India · Founded 1992 · $43.5M raised

Biotech

Headquarters: Mumbai
Employees: 1001–5000
Founded: 1992
Business Model: B2B
Website: marksanspharma.com

Total Funding: $43.5M
Last Round: $43.5M Venture RoundJul 2021
Rounds: 1
Type: Public

About

Marksans Pharma is a publicly listed Indian pharmaceutical company (BSE/NSE: MARKSANS) incorporated in 1992 and headquartered in Andheri West, Mumbai. The company specializes in the research, manufacturing, and marketing of finished dosage pharmaceutical formulations across OTC consumer health and prescription therapeutic segments including pain management, cardiovascular, CNS, oncology, anti-diabetics, and antibiotics. With a presence in over 50 markets worldwide and subsidiaries including Time-Cap Laboratories (USA) and Relonchem (UK), Marksans Pharma employs approximately 2,000 people and markets around 300 products under 1,500+ SKUs globally.

Summary

Marksans Pharma is a Biotech company based in Mumbai, India, founded in 1992. It has raised $43.5M in total across 1 round, most recently a $43.5M Venture Round round in Jul 2021. Investors include OrbiMed.